References
- Agarwal R, Katare OP, Vyas SP. 2001. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 228:43–52.
- Agrawal U, Gupta M, Vyas SP. 2013. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. doi:10.3109/21691401.2013.832683.
- Agrawal Y, Petkar KC, Sawant KK. 2010. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm. 401:93–102.
- Bouwstra JA, Honeywell-Nguyena PL, Goorisa GS. 2003. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res. 42:1–36.
- Carter RB. 1991. Topical capsaicin in the treatment of cutaneous disorders. Drug Dev Res. 22:109–123.
- Carter RB, Francis WR. 1991. Capsaicin desensitisation to plasma extravasation evoked by antidromic C fiber stimulation is not associated with anti-nociception in the rat. Neurosci Lett. 127:49–52.
- Chhabra N, Aseri ML, Goyal V, Sankhla S. 2012. Capsaicin: a promising therapy – a critical reappraisalInt. J Nutri Pharmacol Neurolog Dis. 2:8–15.
- Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. 2007. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 123:148–154.
- El Maghraby GM, Barry BW, Williams AC. 2008. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci. 34: 203–222.
- Fry DW, White JC, Goldman ID. 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem. 90:809–815.
- Gupta M, Goyal AK, Paliwal S, Paliwal R, Mishra N, Vaidya B, et al. 2010. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res. 20:341–350.
- Gupta M, Tiwari S, Vyas SP. 2013. Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharma Dev Technol. 18:550–559.
- Gupta PN, Mishra V, Rawat A, Dubey P, Mahor S, Jain S, et al. 2005. Non-invasive vaccine delivery in transfersomes, niosomes and and liposomes: a comparative study. Int J Pharm. 293:73–82.
- Gupta S, Dube A, Vyas SP. 2007. Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis. J Drug Target. 15:437–444.
- Harada N, Okajima K. 2007. Effect of topical application of capsaicin and its related compounds on dermal insulin-like growth factor-I levels in mice and on facial skin elasticity in humans. Growth Hormone IGF Res. 17:171–176.
- Kenins P. 1982. Response of single nerve fibres to capsaicin applied to the skin. Neurosci Lett. 29:83–88.
- Knudsen N, Rønholt S, Salte RD, Jorgensen L, Thormann T, Basse LH. 2012. Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm Biopharm. 81:532–539.
- Lademann J, Knorr F, Richter H, Blume-Peytavi U, Vogt A, Antoniou C, et al. 2008. Hair follicles – an efficient storage and penetration pathway for topically applied substances. Skin Pharmacol Physiol. 21:150–155.
- Lawrence MJ, Chauhan S, Lawrence SM, Barlow DJ. 1996. The formation, characterization, and stability of nonionic surfactant vesicles. STP Pharm Sci. 6:49–60.
- Magnusson BM, Koskinen LD. 2000. In vitro percutaneous penetration of topically applied capsaicin in relation to in vivo sensation responses. Int J Pharm. 195:55–62.
- Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. 2003. Characterization of vesicles prepared with various nonionic surfactants mixed with cholesterol. Coll Sur B Bioint. 30:129–138.
- Mukherjee B, Patra B, Layek B, Mukherjee A. 2007. Sustained release of acyclovir from nano-liposomes and nano-niosomes: An in vitro study. Int J Nanomed. 2:213–225.
- Pavelic Z, Skalko-Basnet N, Schubert R. 2001. Liposomal gels for vaginal drug delivery. Int J Pharm. 219:139–149.
- Qingzhi LV, Aihua Y, Yanwei X, Houli L, Zhimei S, Jing C. 2009. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 372:191–198.
- Qiu Y, Gao Y, Hu K, Li F. 2008. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release. 129:144–150.
- Raza K, Katare OP, Setia A, Bhatia A, Singh B. 2012. Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes. J Microencapsul. doi:10.3109/02652048.2012.717115.
- Raza M, Negi P, Takyar S, Shukla A, Amarji B, Katare OP. 2011. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul. 28:190–199.
- Schmid MH, Korting HC. 1996. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev. 18:335–342.
- Shah AK, Date AA, Joshi MD, Patraval VB. 2007. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 345:163–171.
- Souto EB, Wissing SA, Barbosa CM, Müller RH. 2004. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 278:71–77.
- Tavano L, Alfano P, Muzzalupoa R, de Cindio B. 2011. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin. Colloids Sur B Biointerfaces. 87:333–339.
- Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 65:403–418.
- Traub M, Marshall K. 2007. Psoriasis-Pathophysiology, conventional, and alternative approaches to treatment. Alternative Med Rev. 12:319–330.
- Turini MPD, Beneforti P, Spinelli M, Malagutti S, Lazzeri M. 2006. Heat/burning sensation induced by topical application of capsaicin on perineal cutaneous area: new approach in diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome. Urology. 67:910–913.